Evidence map›Paper›PMID 37627671›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Antibacterial Activity of Biosynthesized Copper Oxide Nanoparticles (CuONPs) Using

Karla M Flores-Rábago, Daniel Rivera-Mendoza, Alfredo R Vilchis-Nestor, Karla Juarez-Moreno, Ernestina Castro-Longoria

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Eco-friendly synthesis of copper nanoparticles by usingBiochemistry and biophysics reports · 2025
    Article
  15. Biogenic copper and copper oxide nanoparticles to combat multidrug-resistantBiotechnology reports (Amsterdam, Netherlands) · 2025
    Review
  16. Article
  17. Article
  18. Exploring the health benefits ofFrontiers in cellular and infection microbiology · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karla M Flores-RábagoDepartment of Microbiology, Center for Scientific Research and Higher Education of Ensenada (CICESE), Ensenada 22860, Mexico.
Daniel Rivera-MendozaDepartment of Microbiology, Center for Scientific Research and Higher Education of Ensenada (CICESE), Ensenada 22860, Mexico.
Alfredo R Vilchis-NestorSustainable Chemistry Research Joint Center UAEM-UNAM (CCIQS), Toluca 50200, Mexico.ORCID 0000-0001-8490-0900
Karla Juarez-MorenoCenter for Applied Physics and Advanced Technology, UNAM, Juriquilla 76230, Mexico.
Ernestina Castro-LongoriaDepartment of Microbiology, Center for Scientific Research and Higher Education of Ensenada (CICESE), Ensenada 22860, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper oxide nanoparticles (CuONPs) were synthesized using an eco-friendly method and their antimicrobial and biocompatibility properties were determined. The supernatant and extract of the fungus

Indexed as

antibacterialcopper oxide nanoparticlesgreen methodultrastructure

Identifiers

PMID37627671
PMCPMC10451715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.